The potential rescheduling of cannabinoids, particularly at the federal level, is generating considerable buzz within the market. A shift away from Schedule I status, often viewed as outdated and hindering advancement, https://karimykss834418.wikibyby.com/2000666/pot_rescheduling_a_expansion_catalyst